The acceptability of integrated healthcare services for HIV and non-communicable diseases: experiences from patients and healthcare workers in Tanzania.
Acceptability
HIV
NCD; integrated care
Non-communicable diseases
Patients
Providers
Tanzania
Journal
BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677
Informations de publication
Date de publication:
16 May 2022
16 May 2022
Historique:
received:
09
08
2021
accepted:
03
05
2022
entrez:
16
5
2022
pubmed:
17
5
2022
medline:
19
5
2022
Statut:
epublish
Résumé
In sub-Saharan Africa, the prevalence of non-communicable diseases (NCDs) has risen sharply amidst a high burden of communicable diseases. An integrated approach to HIV and NCD care offers the potential of strengthening disease control programmes. We used qualitative methods to explore patients' and care-providers' experiences and perspectives on the acceptability of integrated care for HIV-infection, diabetes mellitus (DM), and hypertension (HT) in Tanzania. A qualitative study was conducted in selected health facilities in Dar es Salaam and Coastal regions, which had started to provide integrated care and management for HIV, DM, and HT using a single research clinic for patients with one or more of these conditions. In-depth interviews were held with patients and healthcare providers at three time points: At enrolment (prior to the patient receiving integrated care, at the mid-line and at the study end). A minimum of 16 patients and 12 healthcare providers were sampled for each time point. Observation was also carried out in the respective clinics during pre- and mid-line phases. The Theoretical Framework of Acceptability (TFA) underpinned the structure and interpretation of the combined qualitative and observational data sets. Patients and healthcare providers revealed a positive attitude towards the integrated care delivery model at the mid-line and at study end-time points. High acceptability was related to increased exposure to service integration in terms of satisfaction with the clinic setup, seating arrangements and the provision of medical care services. Satisfaction also centred on the patients' freedom to move from one service point to another, and to discuss the services and their own health status amongst themselves. Adherence to medication and scheduling of clinic appointments appeared central to the patient-provider relationship as an aspect in the provision of quality services. Multi-condition health education, patient time and cost-saving, and detection of undiagnosed disease conditions emerged as benefits. On the other hand, a few challenges included long waiting times and limited privacy in lower and periphery health facilities due to infrastructural limitations. The study reveals a continued high level of acceptability of the integrated care model among study participants in Tanzania. This calls for evaluation in a larger and a comparative study. Nevertheless, much more concerted efforts are necessary to address structural challenges and maximise privacy and confidentiality.
Sections du résumé
BACKGROUND
BACKGROUND
In sub-Saharan Africa, the prevalence of non-communicable diseases (NCDs) has risen sharply amidst a high burden of communicable diseases. An integrated approach to HIV and NCD care offers the potential of strengthening disease control programmes. We used qualitative methods to explore patients' and care-providers' experiences and perspectives on the acceptability of integrated care for HIV-infection, diabetes mellitus (DM), and hypertension (HT) in Tanzania.
METHODS
METHODS
A qualitative study was conducted in selected health facilities in Dar es Salaam and Coastal regions, which had started to provide integrated care and management for HIV, DM, and HT using a single research clinic for patients with one or more of these conditions. In-depth interviews were held with patients and healthcare providers at three time points: At enrolment (prior to the patient receiving integrated care, at the mid-line and at the study end). A minimum of 16 patients and 12 healthcare providers were sampled for each time point. Observation was also carried out in the respective clinics during pre- and mid-line phases. The Theoretical Framework of Acceptability (TFA) underpinned the structure and interpretation of the combined qualitative and observational data sets.
RESULTS
RESULTS
Patients and healthcare providers revealed a positive attitude towards the integrated care delivery model at the mid-line and at study end-time points. High acceptability was related to increased exposure to service integration in terms of satisfaction with the clinic setup, seating arrangements and the provision of medical care services. Satisfaction also centred on the patients' freedom to move from one service point to another, and to discuss the services and their own health status amongst themselves. Adherence to medication and scheduling of clinic appointments appeared central to the patient-provider relationship as an aspect in the provision of quality services. Multi-condition health education, patient time and cost-saving, and detection of undiagnosed disease conditions emerged as benefits. On the other hand, a few challenges included long waiting times and limited privacy in lower and periphery health facilities due to infrastructural limitations.
CONCLUSION
CONCLUSIONS
The study reveals a continued high level of acceptability of the integrated care model among study participants in Tanzania. This calls for evaluation in a larger and a comparative study. Nevertheless, much more concerted efforts are necessary to address structural challenges and maximise privacy and confidentiality.
Identifiants
pubmed: 35578274
doi: 10.1186/s12913-022-08065-4
pii: 10.1186/s12913-022-08065-4
pmc: PMC9112557
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
655Subventions
Organisme : Medical Research Council
ID : MC_UU_00027/4
Pays : United Kingdom
Informations de copyright
© 2022. The Author(s).
Références
AIDS. 2018 Jul 1;32 Suppl 1:S21-S32
pubmed: 29952787
Cochrane Database Syst Rev. 2001;(4):CD003318
pubmed: 11687187
PLoS One. 2020 Jul 9;15(7):e0235542
pubmed: 32645054
Glob Health Action. 2017;10(1):1321279
pubmed: 28598724
BMC Public Health. 2016 Dec 12;16(1):1243
pubmed: 27955664
J Public Health Policy. 2004;25(2):137-58
pubmed: 15255381
J Trop Med. 2012;2012:137460
pubmed: 23056058
Int J Tuberc Lung Dis. 2008 Mar;12(3 Suppl 1):79-84
pubmed: 18302828
Malawi Med J. 2018 Sep;30(3):211-214
pubmed: 30627358
BMC Med. 2015 May 29;13:126
pubmed: 26021319
PLoS One. 2016 Oct 20;11(10):e0164634
pubmed: 27764128
Ethiop J Health Sci. 2017 Sep;27(5):473-480
pubmed: 29217952
AIDS. 2011 Jul 31;25(12):1471-9
pubmed: 21572309
Cochrane Database Syst Rev. 2006 Apr 19;(2):CD003318
pubmed: 16625576
BMC Public Health. 2016 Aug 08;16:741
pubmed: 27503191
Ir J Med Sci. 2017 Nov;186(4):827-834
pubmed: 28477328
Hypertension. 2007 Dec;50(6):1012-8
pubmed: 17954720
Trans R Soc Trop Med Hyg. 2015 Jul;109(7):440-6
pubmed: 25997923
J Acquir Immune Defic Syndr. 2017 Aug 1;75(4):472-479
pubmed: 28640065
Int J Integr Care. 2015 Oct 12;15:e038
pubmed: 26528101
Trans R Soc Trop Med Hyg. 2019 Dec 1;113(12):809-812
pubmed: 30265362
PLoS One. 2019 Feb 22;14(2):e0212296
pubmed: 30794591
Trop Med Int Health. 2015 Oct;20(10):1265-70
pubmed: 25962952
Int J Qual Health Care. 2007 Dec;19(6):349-57
pubmed: 17872937
Medicine (Baltimore). 2018 Apr;97(16):e0380
pubmed: 29668591
J Acquir Immune Defic Syndr. 2014 Sep 1;67 Suppl 1:S87-95
pubmed: 25117965
BMC Public Health. 2019 May 6;19(1):511
pubmed: 31060545
J Acquir Immune Defic Syndr. 2012 Jun 1;60(2):e29-35
pubmed: 22395671
BMJ Glob Health. 2020 Jul;5(7):
pubmed: 32636311
BMJ Open. 2021 Nov 2;11(11):e053412
pubmed: 34728457
J Diabetes Res. 2018 Feb 18;2018:9262395
pubmed: 29670916
Adm Policy Ment Health. 2011 Mar;38(2):65-76
pubmed: 20957426
Lancet Diabetes Endocrinol. 2017 Aug;5(8):622-667
pubmed: 28688818
Lancet Glob Health. 2019 Oct;7(10):e1375-e1387
pubmed: 31537368
PLoS One. 2016 Feb 22;11(2):e0149412
pubmed: 26901854
Cochrane Database Syst Rev. 2011 Jul 06;(7):CD003318
pubmed: 21735392
Br J Health Psychol. 2018 Sep;23(3):519-531
pubmed: 29453791